Officials mull school closures and evacuation orders as the system expected to become Hurricane Helene draws closer.

Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin ...

Williamsburg Cultural Council taking applicationsWILLIAMSBURG — The Williamsburg Cultural Council is accepting applications for Mass Cultural Council’s fiscal 2025 cultural grants. The new grant cycle ...

Study will aim to establish safety and clinical efficacy PETACH TIKVA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE ...

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today presented positive, mature data from its ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Metastatic Uveal Melanoma.

Lundin Mining Corp ( TSX:LUN) saw a reduction of 221,480 shares, a -9.82% decrease, impacting the portfolio by -0.36%. The stock traded at an average price of C$15.42 during the quarter and has ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase I for T-Cell Lymphomas.

NCT05911217), an investigator-initiated trial that is currently in the start-up phase for GC/GEJ, and a Phase I clinical ...